Abstract:
The first edition of \'A Standardized Pathology Report for Gastric Cancer\' was initiated by the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists and published 17 years ago. Since then, significant advances have been made in the pathologic diagnosis, molecular genetics, and management of gastric cancer (GC). To reflect those changes, a committee for publishing a second edition of the report was formed within the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists. This second edition consists of two parts: standard data elements and conditional data elements. The standard data elements contain the basic pathologic findings and items necessary to predict the prognosis of GC patients, and they are adequate for routine surgical pathology service. Other diagnostic and prognostic factors relevant to adjuvant therapy, including molecular biomarkers, are classified as conditional data elements to allow each pathologist to selectively choose items appropriate to the environment in their institution. We trust that the standardized pathology report will be helpful for GC diagnosis and facilitate large-scale multidisciplinary collaborative studies.
摘要:
第一版“胃癌标准化病理学报告”由韩国病理学学会胃肠道病理学研究小组发起,并于17年前出版。从那以后,在病理诊断方面取得了重大进展,分子遗传学,和胃癌(GC)的管理。为了反映这些变化,在韩国病理学家学会的胃肠道病理学研究组内成立了一个委员会来发表该报告的第二版.第二版由两部分组成:标准数据元素和条件数据元素。标准数据元素包含基本病理结果和预测GC患者预后所必需的项目。它们足以进行常规的手术病理服务。与辅助治疗相关的其他诊断和预后因素,包括分子生物标志物,被分类为条件数据元素,以允许每个病理学家选择性地选择适合其机构环境的项目。我们相信标准化的病理报告将有助于GC诊断并促进大规模的多学科合作研究。